Collectively, these results suggest that some biochemical functions of Shank exhibit this unusual pattern of dose sensitivity and consequently could contribute to the pathophysiology of human Shankopathies (i.e. Shank3 mutations, CNVs, or PMS). The gene discussed is SHANK2; the disease is premenstrual tension.